Loading…
Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab
Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an i...
Saved in:
| Published in: | Ocular immunology and inflammation 2008-01, Vol.16 (5-6), p.236-238 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163 |
| container_end_page | 238 |
| container_issue | 5-6 |
| container_start_page | 236 |
| container_title | Ocular immunology and inflammation |
| container_volume | 16 |
| creator | Sisk, Robert A. Davis, Janet L. Dubovy, Sander R. Smiddy, William E. |
| description | Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment. |
| doi_str_mv | 10.1080/09273940802409951 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_09273940802409951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20185526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163</originalsourceid><addsrcrecordid>eNqFkV1rFDEUhkNR2rX2B3hT5kqvRvP9QXtTS6uFQi_8uDQksxknJTPZJpmW9debZbeICOvVCZznfTnkAeANgu8RlPADVFgQResTU6gUQwdggQSlLYNCvgCLzb6tgDwCr3K-hxBSpdAhOEIKckYxXIAfX9bjypTBFd81d6uhDCaM3jTXMYT45KefzXdfkutKHNdNH1NzNS3jM1Z8bi764lJzM5VkHjekCc1H92g6_2sejX0NXvYmZHeym8fg2_XV18vP7e3dp5vLi9u2o1yUlllqsUWCcdQrKRFB9VTOrCWSMCkoY5b1FkpJuYSQU0Mkcg5JjJeIMcTJMXi37V2l-DC7XPToc-dCMJOLc9a1ghMsBK3k270kV1JIAvl_QQyRZAxvQLQFuxRzTq7Xq-RHk9YaQb3xpP_xVDOnu_LZjm75J7ETU4HzLeCn-uujeYopLHUx6xBTn8zU-azJvv6zv-JD9VKGziSn7-Ocpupiz3W_AZCSsbc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20185526</pqid></control><display><type>article</type><title>Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Sisk, Robert A. ; Davis, Janet L. ; Dubovy, Sander R. ; Smiddy, William E.</creator><creatorcontrib>Sisk, Robert A. ; Davis, Janet L. ; Dubovy, Sander R. ; Smiddy, William E.</creatorcontrib><description>Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.</description><identifier>ISSN: 0927-3948</identifier><identifier>EISSN: 1744-5078</identifier><identifier>DOI: 10.1080/09273940802409951</identifier><identifier>PMID: 19065420</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Administration, Oral ; Aged, 80 and over ; Anti-Inflammatory Agents - administration & dosage ; Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal, Humanized ; Azathioprine - administration & dosage ; Bevacizumab ; Drug Therapy, Combination ; endophthalmitis ; Endophthalmitis - surgery ; Eye Enucleation ; Humans ; Injections ; intravitreal bevacizumab ; Male ; Ophthalmia, Sympathetic - etiology ; Ophthalmia, Sympathetic - pathology ; Ophthalmia, Sympathetic - physiopathology ; Ophthalmia, Sympathetic - surgery ; phacoanaphylactic endophthalmitis ; Postoperative Complications ; Prednisone - administration & dosage ; Retrospective Studies ; sympathetic ophthalmia ; Visual Acuity ; Vitrectomy ; Vitreous Body</subject><ispartof>Ocular immunology and inflammation, 2008-01, Vol.16 (5-6), p.236-238</ispartof><rights>2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163</citedby><cites>FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19065420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sisk, Robert A.</creatorcontrib><creatorcontrib>Davis, Janet L.</creatorcontrib><creatorcontrib>Dubovy, Sander R.</creatorcontrib><creatorcontrib>Smiddy, William E.</creatorcontrib><title>Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab</title><title>Ocular immunology and inflammation</title><addtitle>Ocul Immunol Inflamm</addtitle><description>Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.</description><subject>Administration, Oral</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents - administration & dosage</subject><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Azathioprine - administration & dosage</subject><subject>Bevacizumab</subject><subject>Drug Therapy, Combination</subject><subject>endophthalmitis</subject><subject>Endophthalmitis - surgery</subject><subject>Eye Enucleation</subject><subject>Humans</subject><subject>Injections</subject><subject>intravitreal bevacizumab</subject><subject>Male</subject><subject>Ophthalmia, Sympathetic - etiology</subject><subject>Ophthalmia, Sympathetic - pathology</subject><subject>Ophthalmia, Sympathetic - physiopathology</subject><subject>Ophthalmia, Sympathetic - surgery</subject><subject>phacoanaphylactic endophthalmitis</subject><subject>Postoperative Complications</subject><subject>Prednisone - administration & dosage</subject><subject>Retrospective Studies</subject><subject>sympathetic ophthalmia</subject><subject>Visual Acuity</subject><subject>Vitrectomy</subject><subject>Vitreous Body</subject><issn>0927-3948</issn><issn>1744-5078</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNqFkV1rFDEUhkNR2rX2B3hT5kqvRvP9QXtTS6uFQi_8uDQksxknJTPZJpmW9debZbeICOvVCZznfTnkAeANgu8RlPADVFgQResTU6gUQwdggQSlLYNCvgCLzb6tgDwCr3K-hxBSpdAhOEIKckYxXIAfX9bjypTBFd81d6uhDCaM3jTXMYT45KefzXdfkutKHNdNH1NzNS3jM1Z8bi764lJzM5VkHjekCc1H92g6_2sejX0NXvYmZHeym8fg2_XV18vP7e3dp5vLi9u2o1yUlllqsUWCcdQrKRFB9VTOrCWSMCkoY5b1FkpJuYSQU0Mkcg5JjJeIMcTJMXi37V2l-DC7XPToc-dCMJOLc9a1ghMsBK3k270kV1JIAvl_QQyRZAxvQLQFuxRzTq7Xq-RHk9YaQb3xpP_xVDOnu_LZjm75J7ETU4HzLeCn-uujeYopLHUx6xBTn8zU-azJvv6zv-JD9VKGziSn7-Ocpupiz3W_AZCSsbc</recordid><startdate>20080101</startdate><enddate>20080101</enddate><creator>Sisk, Robert A.</creator><creator>Davis, Janet L.</creator><creator>Dubovy, Sander R.</creator><creator>Smiddy, William E.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20080101</creationdate><title>Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab</title><author>Sisk, Robert A. ; Davis, Janet L. ; Dubovy, Sander R. ; Smiddy, William E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Administration, Oral</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents - administration & dosage</topic><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Azathioprine - administration & dosage</topic><topic>Bevacizumab</topic><topic>Drug Therapy, Combination</topic><topic>endophthalmitis</topic><topic>Endophthalmitis - surgery</topic><topic>Eye Enucleation</topic><topic>Humans</topic><topic>Injections</topic><topic>intravitreal bevacizumab</topic><topic>Male</topic><topic>Ophthalmia, Sympathetic - etiology</topic><topic>Ophthalmia, Sympathetic - pathology</topic><topic>Ophthalmia, Sympathetic - physiopathology</topic><topic>Ophthalmia, Sympathetic - surgery</topic><topic>phacoanaphylactic endophthalmitis</topic><topic>Postoperative Complications</topic><topic>Prednisone - administration & dosage</topic><topic>Retrospective Studies</topic><topic>sympathetic ophthalmia</topic><topic>Visual Acuity</topic><topic>Vitrectomy</topic><topic>Vitreous Body</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sisk, Robert A.</creatorcontrib><creatorcontrib>Davis, Janet L.</creatorcontrib><creatorcontrib>Dubovy, Sander R.</creatorcontrib><creatorcontrib>Smiddy, William E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Ocular immunology and inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sisk, Robert A.</au><au>Davis, Janet L.</au><au>Dubovy, Sander R.</au><au>Smiddy, William E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab</atitle><jtitle>Ocular immunology and inflammation</jtitle><addtitle>Ocul Immunol Inflamm</addtitle><date>2008-01-01</date><risdate>2008</risdate><volume>16</volume><issue>5-6</issue><spage>236</spage><epage>238</epage><pages>236-238</pages><issn>0927-3948</issn><eissn>1744-5078</eissn><abstract>Purpose: To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab. Design: Retrospective case report. Methods: An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated. Results: Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine. Conclusions: Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>19065420</pmid><doi>10.1080/09273940802409951</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0927-3948 |
| ispartof | Ocular immunology and inflammation, 2008-01, Vol.16 (5-6), p.236-238 |
| issn | 0927-3948 1744-5078 |
| language | eng |
| recordid | cdi_informahealthcare_journals_10_1080_09273940802409951 |
| source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
| subjects | Administration, Oral Aged, 80 and over Anti-Inflammatory Agents - administration & dosage Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Azathioprine - administration & dosage Bevacizumab Drug Therapy, Combination endophthalmitis Endophthalmitis - surgery Eye Enucleation Humans Injections intravitreal bevacizumab Male Ophthalmia, Sympathetic - etiology Ophthalmia, Sympathetic - pathology Ophthalmia, Sympathetic - physiopathology Ophthalmia, Sympathetic - surgery phacoanaphylactic endophthalmitis Postoperative Complications Prednisone - administration & dosage Retrospective Studies sympathetic ophthalmia Visual Acuity Vitrectomy Vitreous Body |
| title | Sympathetic Ophthalmia Following Vitrectomy for Endophthalmitis After Intravitreal Bevacizumab |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A44%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sympathetic%20Ophthalmia%20Following%20Vitrectomy%20for%20Endophthalmitis%20After%20Intravitreal%20Bevacizumab&rft.jtitle=Ocular%20immunology%20and%20inflammation&rft.au=Sisk,%20Robert%20A.&rft.date=2008-01-01&rft.volume=16&rft.issue=5-6&rft.spage=236&rft.epage=238&rft.pages=236-238&rft.issn=0927-3948&rft.eissn=1744-5078&rft_id=info:doi/10.1080/09273940802409951&rft_dat=%3Cproquest_infor%3E20185526%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c467t-5b4b2b17561f98813100465bb383587455b5fb0884680064a381ee1822d155163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20185526&rft_id=info:pmid/19065420&rfr_iscdi=true |